Qiming-backed genomic testing firm Berry Oncology closes over $99m Series B1 round

Qiming-backed genomic testing firm Berry Oncology closes over $99m Series B1 round

Eudora Wang

05 August, 2021

Berry GenomicsBerry Oncologycancer screeningChina Merchants Capitalgenetic testingQiming Venture Partners

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.